Hormone Therapy
Latest News
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Urology Times
1
Treatment interruptions in prostate cancer: Balancing PSA kinetics and quality of life
2
Cretostimogene reduces recurrence risk by 68% in phase 3 PIVOT-006 trial in NMIBC
3
FDA approves durvalumab plus enfortumab vedotin for cisplatin-ineligible MIBC
4
American Cancer Society updates prostate cancer screening guidelines, recommends regular PSA testing
5


